Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dapagliflozin”

529 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 529 results

Post-approval studies (Phase 4)Study completedNCT03338855
What this trial is testing

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Who this might be right for
Diabetes Mellitus, Type 2Skeletal Muscle Insulin Sensitivity
AstraZeneca 26
Not applicableStudy completedNCT03156985
What this trial is testing

Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 3,000
Post-approval studies (Phase 4)UnknownNCT04120623
What this trial is testing

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University 100
Early research (Phase 1)Study completedNCT00538174
What this trial is testing

Phase I Multiple-Ascending Dose (Japan)

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 36
Not applicableStudy completedNCT01439854
What this trial is testing

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

Who this might be right for
Insulin SensitivityMultiple Mitochondrial Dysfunctions Syndrome
The University of Texas Health Science Center at San Antonio 18
Testing effectiveness (Phase 2)UnknownNCT04475042
What this trial is testing

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure, Diastolic
Mariëlle Scheffer 26
Post-approval studies (Phase 4)UnknownNCT06365541
What this trial is testing

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

Who this might be right for
The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
The People's Hospital of Gaozhou 40
Early research (Phase 1)Study completedNCT07404137
What this trial is testing

Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Who this might be right for
Healthy Participants
AstraZeneca 26
Not applicableStudy completedNCT05795400
What this trial is testing

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+1 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Post-approval studies (Phase 4)Study completedNCT02426541
What this trial is testing

Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 55
Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Post-approval studies (Phase 4)Study completedNCT05621551
What this trial is testing

Dapagliflozin Therapy In Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
China National Center for Cardiovascular Diseases 178
Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Early research (Phase 1)Study completedNCT07333742
What this trial is testing

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

Who this might be right for
Fed ConditionsHealthy Volunteer
LG Chem 50
Early research (Phase 1)Not Yet RecruitingNCT07396844
What this trial is testing

The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers

Who this might be right for
HealthyFastingFed
LG Chem 28
Not applicableStudy completedNCT06778330
What this trial is testing

The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension

Who this might be right for
Heart Failure NYHA Class II
Fayoum University 100
Large-scale testing (Phase 3)Study completedNCT01217892
What this trial is testing

Evaluation of Dapagliflozin Taken Twice-daily

Who this might be right for
Type 2 Diabetes
AstraZeneca 400
Large-scale testing (Phase 3)Study completedNCT02984644
What this trial is testing

Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin

Who this might be right for
Type II; Diabetes
The University of Texas Health Science Center at San Antonio 30
Large-scale testing (Phase 3)Study completedNCT04170998
What this trial is testing

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Type2 Diabetes
Dong-A ST Co., Ltd. 283
Post-approval studies (Phase 4)UnknownNCT04570865
What this trial is testing

Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®

Who this might be right for
Heart Failure, Systolic
Scripps Health 100
Load More Results